SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $290,151,348 |
| Positions | 6 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Pharvaris N.V. | PHVS | COM | $165,243,331 | 4,778,581 |
| CYTOKINETICS INC | CYTK | COM | $60,884,867 | 714,695 |
| Eikon Therapeutics, Inc. | EIKN | COM | $25,365,050 | 1,943,682 |
| Relay Therapeutics, Inc. | RLAY | COM | $23,387,500 | 1,250,000 |
| Xenon Pharmaceuticals Inc. | XENE | COM | $9,657,600 | 160,000 |
| Crinetics Pharmaceuticals, Inc. | CRNX | COM | $5,613,000 | 150,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.